Kawakami Satoru, Kihara Kazunori, Fujii Yasuhisa, Masuda Hitoshi, Kobayashi Tsuyoshi, Kageyama Yukio
Department of Urology and Reproductive Medicine, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Int J Urol. 2004 Aug;11(8):613-8. doi: 10.1111/j.1442-2042.2004.00863.x.
The optimal biopsy strategy for prostate cancer detection, especially in men with isolated prostate-specific antigen (PSA) elevation, remains to be defined. We evaluated diagnostic yield and safety of transrectal ultrasound (TRUS)-guided transperineal systematic 14-core biopsy and compared the spatial distribution of cancer foci detected with this technique in men with and without abnormality on digital rectal examination (DRE).
In a prospective study, 289 men aged between 50 and 87 years (median age, 70 years) underwent TRUS-guided transperineal systematic 14-core prostate biopsy because of elevated PSA and/or abnormal DRE findings. Using the fan technique, 12 cores from the peripheral zone and two cores from the transition zone were obtained systematically. To characterize the spatial distribution of cancer positive cores, site-specific overall and unique cancer detection rates were compared between stage T1c and T2 cancers.
Prostate cancer was detected in 105 of the 289 patients (36%). Major complications requiring prolonged hospital stay or re-hospitalization during a 4-week postbiopsy period were rare (1.4%). Sixty-seven stage T1c cancers were identified. These cancers were associated with significantly lower PSA and a smaller number of cancer positive cores when compared with stage T2 cancers (n= 38). The overall cancer detection rate was highest at the anterior peripheral zone and the posterior peripheral zone in stage T1c and stage T2 cancers, respectively. The unique cancer detection rate at the anterior peripheral zone was significantly higher in stage T1c cancers than in stage T2 cancers. Therefore, when the prostate is extensively biopsied using the transperineal approach, cancer positive cores are characteristically distributed anteriorly in stage T1c cancers and posteriorly in stage T2 cancers.
TRUS-guided transperineal systematic 14-core biopsy showed an apico-anterior distribution of cancer foci in stage T1c prostate cancers.
前列腺癌检测的最佳活检策略,尤其是在孤立性前列腺特异性抗原(PSA)升高的男性中,仍有待确定。我们评估了经直肠超声(TRUS)引导下经会阴系统性14针活检的诊断率和安全性,并比较了该技术在直肠指检(DRE)正常和异常男性中检测到的癌灶的空间分布。
在一项前瞻性研究中,289名年龄在50至87岁(中位年龄70岁)之间的男性因PSA升高和/或DRE检查结果异常接受了TRUS引导下经会阴系统性14针前列腺活检。采用扇形技术,系统地从外周区获取12针组织,从移行区获取2针组织。为了描述癌阳性针的空间分布,比较了T1c期和T2期癌症部位特异性的总体和独特癌症检出率。
289例患者中有105例(36%)检测到前列腺癌。活检后4周内需要延长住院时间或再次住院的主要并发症很少见(1.4%)。共识别出67例T1c期癌症。与T2期癌症(n = 38)相比,这些癌症的PSA水平显著较低,癌阳性针数较少。T1c期和T2期癌症的总体癌症检出率分别在前外周区和后外周区最高。T1c期癌症在前外周区的独特癌症检出率显著高于T2期癌症。因此,当采用经会阴途径对前列腺进行广泛活检时,癌阳性针在T1c期癌症中特征性地分布在前部,在T2期癌症中分布在后部。
TRUS引导下经会阴系统性14针活检显示T1c期前列腺癌的癌灶呈尖前部分布。